Skip to main content

and
  1. No Access

    Article

    Predictive factors and the important role of detectable prostate-specific antigen for detection of clinical recurrence and cancer-specific mortality following robot-assisted radical prostatectomy

    To evaluate predictive factors associated with detectable prostate-specific antigen (PSA) and describe clinical recurrence (CR) and cancer-specific mortality (CSM) after robot-assisted radical prostatectomy (R...

    S. García-Barreras, F. Rozet, I. Nunes-Silva in Clinical and Translational Oncology (2018)

  2. No Access

    Article

    Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy

    The aim of the study was to identify the appropriate level of Charlson comorbidity index (CCI) in older patients (>70 years) with high-risk prostate cancer (PCa) to achieve survival benefit following radical p...

    A. Sivaraman, G. Ordaz Jurado, X. Cathelineau, Eric Barret in World Journal of Urology (2016)

  3. No Access

    Article

    Apport de la laparoscopie dans la chirurgie radicale du cancer de la prostate

    La prostatectomie radicale est le traitement de référence du cancer de prostate localisé. Le développement de la laparoscopie en urologie, d’abord pour la nephrectomie puis pour la prostatectomie, est le signe...

    X. Cathelineau, F. Rozet, E. Barret, G. Vallancien in ONCOLOGIE (2004)